Fig. 2
From: FOXD3 may be a new cellular target biomarker as a hypermethylation gene in human ovarian cancer
Microarray analyses for ovarian cancer patients. a Density of methylated DNA intensity for each sample. The quality of the data for each specimen was visualized by density plot. b Multi-dimensional scaling (MDS) plot showed differential clustering of control vs. tumor tissues. c Dendrogram produced for 467,324 probes in control and tumor tissues. d Genetic and epigenetic annotation information revealed the distribution of top 1000 differentially methylated imprinted CpG sites